Stockreport

Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline [Yahoo! Finance]

Elite Pharmaceuticals, Inc.  (ELTP) 
NASDAQ:AMEX Investor Relations: ir.elitepharma.com
PDF the S&P 500 index's decline of 2% during the same period. Over the past month, Elite Pharmaceuticals' stock plunged 8.5%, contrasting with a modest 0.6% gain for the S&P [Read more]